Verrica Pharmaceuticals VRCA Balance Sheet (2017-2026)

NASDAQ VRCA
$4.46 -0.14 (-3.04%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Verrica Pharmaceuticals Quarterly Balance Sheet

Periods 36 quarters
Latest Jun 2026

Verrica Pharmaceuticals reported total assets of $36.02M and total liabilities of $31.71M for the quarter ended Jun 2026, down 7.9% year over year. This balance sheet covers 36 quarters of results from Sep 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
20.44M15.75M50.41M45.43M32.47M34.27M60.00M55.14M84.31M69.55M48.94M31.93M23.00M46.33M29.59M15.40M21.10M30.15M20.60M11.20M
Short-term InvestmentsInvestments (Current)
Cash & Current Investments
20.44M15.75M50.41M45.43M32.47M34.27M60.00M55.14M84.31M69.55M48.94M31.93M23.00M46.33M29.59M15.40M21.10M30.15M20.60M11.20M
Receivables - NetNet Receivables
3.95M4.25M7.00M10.03M0.05M5.61M9.20M7.05M5.26M7.72M10.94M
Receivables - OtherOther Receivables
0.43M0.22M0.42M0.10M0.06M0.17M0.13M0.17M0.59M0.18M0.08M0.03M0.05M2.30M
Receivables
0.10M4.07M4.42M7.59M10.21M0.08M0.08M5.65M9.20M7.05M5.26M7.72M13.24M
Raw Materials
0.12M0.42M1.15M1.15M1.21M1.08M1.05M1.01M
Work In Process
0.49M0.67M0.68M0.75M0.66M0.18M0.52M
Finished Goods
0.16M0.12M0.68M0.87M0.63M0.72M1.23M0.99M
Inventory
0.28M1.02M2.50M2.70M2.58M2.46M2.46M2.52M2.30M2.24M1.97M2.71M
Prepaid Assets
3.66M3.97M3.44M2.73M3.52M4.36M3.09M1.46M3.07M2.54M2.34M2.48M2.56M2.31M1.77M1.49M3.59M2.80M2.37M2.62M
Current Assets
83.16M74.33M65.77M57.34M43.40M39.12M63.10M56.78M91.72M77.53M61.38M47.32M28.19M51.18M39.47M36.78M36.27M42.54M34.13M32.64M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
3.67M3.89M4.16M4.04M4.02M3.89M3.80M3.69M3.56M1.05M0.94M0.71M0.65M0.59M0.54M0.32M0.23M0.21M0.19M0.18M
Other Non-Current Assets
0.26M0.29M40.00M40.00M0.22M0.28M0.37M0.44M0.53M0.45M0.45M0.45M0.54M0.38M0.38M0.38M0.38M0.38M0.64M0.64M
Non-Current Assets
5.60M5.80M5.84M6.09M5.75M5.61M5.54M5.42M5.42M4.07M4.93M4.69M4.74M2.96M2.70M2.33M4.62M4.59M4.66M3.38M
Assets
88.76M80.12M71.62M63.44M49.15M44.72M68.64M62.20M97.15M81.60M66.31M52.01M32.93M54.13M42.18M39.11M40.90M47.13M38.79M36.02M
Liabilities
Current Liabilities
Accounts Payables
0.90M0.84M0.53M0.71M0.14M0.51M0.57M2.06M1.93M2.46M2.53M1.15M0.97M1.90M1.44M2.32M1.58M2.07M2.19M1.60M
Notes Payables
41.35M41.69M42.00M42.29M
Payables
42.25M42.54M42.53M43.01M0.14M0.51M0.57M2.06M1.93M2.46M2.53M1.15M0.97M1.90M1.44M2.32M1.58M2.07M2.19M1.60M
Accumulated Expenses
3.88M3.27M2.01M2.41M2.65M2.65M1.77M3.37M9.10M13.86M15.83M17.85M18.90M13.51M14.48M13.10M12.60M12.84M12.25M14.55M
Other Accumulated Expenses
0.24M0.25M0.22M0.24M0.28M0.24M0.32M0.30M0.43M0.10M0.17M0.37M4.00M
Short term Debt
12.94M12.82M12.67M12.46M
Current Leases
0.01M0.01M0.01M0.01M0.03M0.38M0.68M0.72M0.85M0.35M0.33M0.32M0.37M0.41M0.40M0.60M
Current Deferred Revenue
0.48M1.56M0.78M1.03M1.33M
Total Current Liabilities
46.37M46.05M44.80M45.71M3.08M3.46M2.64M5.73M11.37M17.02M19.36M20.05M21.03M29.01M29.40M29.22M28.91M16.44M16.22M22.44M
Non-Current Liabilities
Capital Leases
0.02M0.02M0.01M0.01M0.08M1.03M1.76M1.76M1.98M0.77M0.66M0.58M0.63M0.64M0.55M0.79M
Preferred Stock Liabilities
Operating Leases
1.51M1.45M1.38M1.38M1.30M1.23M1.15M1.07M0.99M0.91M0.82M0.74M0.67M0.58M0.50M0.42M0.33M0.24M0.15M0.06M
Other Non-Current Liabilities
0.01M0.01M2.65M2.39M1.80M4.69M5.07M5.81M8.41M
Total Non-Current Liabilities
6.79M54.84M61.83M61.35M58.36M54.80M53.25M17.32M16.92M23.30M
Total Liabilities
47.90M47.52M46.20M47.10M4.38M4.69M3.79M6.80M54.84M61.83M64.80M65.31M66.98M63.99M60.75M56.59M57.94M22.39M22.73M31.71M
Shareholder's Equity
Total Debt
41.35M41.69M42.00M42.29M12.94M12.82M12.67M12.46M
Common Equity
40.85M32.60M25.42M16.33M44.77M40.03M64.85M55.40M42.30M19.76M1.51M-13.30M-34.05M-9.86M-18.58M-17.48M-17.04M24.74M16.05M4.31M
Liabilities and Shareholders Equity
88.76M80.12M71.62M63.44M49.15M44.72M68.64M62.20M97.15M81.60M66.31M52.01M32.93M54.13M42.18M39.11M40.90M47.13M38.79M36.02M
Retained Earnings
-129.43M-138.97M-147.44M-157.60M-157.52M-163.45M-170.04M-181.03M-205.83M-230.45M-250.80M-268.00M-290.82M-307.03M-316.80M-316.60M-316.84M-324.91M-334.60M-347.75M
Treasury Shares
0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.01M0.11M0.11M0.11M0.01M0.11M0.01M0.01M0.01M0.01M0.01M

Verrica Pharmaceuticals Balance Sheet API

Pull Verrica Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VRCA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY